Region: Global
Category: Pharmaceuticals

Global Pharmaceuticals

(23,560 reports matching your criteria)
  • Cardiovascular Drugs

    ... at a CAGR of 3.5% over the analysis period 2023-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$57.7 Billion by the end of the ... Read More

  • Lung Cancer Therapeutics

    ... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach ... Read More

  • Organic Foods and Beverages

    ... reach US$681.4 Billion by 2030, growing at a CAGR of 14.1% over the analysis period 2023-2030. Organic Fruits & Vegetables, one of the segments analyzed in the report, is expected to record a 15.3% CAGR ... Read More

  • Rheumatoid Arthritis Therapeutics

    ... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Pharmaceuticals Molecule, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$28.0 Billion by ... Read More

  • Breast Cancer Therapeutics

    ... by 2030, growing at a CAGR of 12.3% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by ... Read More

  • Cosmetic Procedures and Products

    ... reach US$60.0 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Facial Injectable, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach ... Read More

  • Condoms

    ... of 5.8% over the analysis period 2023-2030. Natural Condoms, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.2 Billion by the end of the analysis period. ... Read More

  • Branded Apparel

    ... at a CAGR of 2.4% over the analysis period 2023-2030. Men`s Branded Apparel, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$203.3 Billion by the end ... Read More

  • Prostate Cancer Therapeutics

    ... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$21.0 Billion by ... Read More

  • 3D Dental Scanners

    ... by 2030, growing at a CAGR of 10.2% over the analysis period 2023-2030. Desktop / Laboratory Scanners, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$1.2 ... Read More

  • Ablation Technologies

    ... at a CAGR of 9.8% over the analysis period 2023-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$3.7 Billion by the end of ... Read More

  • Continuous Renal Replacement Therapy (CRRT)

    ... is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is expected to record ... Read More

  • Throat Lozenges

    ... at a CAGR of 4.8% over the analysis period 2023-2030. Hard Candy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$4.9 Billion by the end of ... Read More

  • Anxiety Disorder Treatment

    ... by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$4.9 Billion by the ... Read More

  • Glucosamine

    ... of 6.8% over the analysis period 2023-2030. Nutritional Supplements Application, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More

  • Autologous Matrix-Induced Chondrogenesis (AMIC)

    ... reach US$278.0 Million by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Collagen, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$158.8 ... Read More

  • Automotive Lighting

    ... at a CAGR of 6.0% over the analysis period 2023-2030. Halogen Lighting, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$28.2 Billion by the end of ... Read More

  • Pet Dietary Supplements

    ... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Dietary Supplements for Dogs, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$2.3 ... Read More

  • Global Lyophilized Reagent Beads Market Research Report 2024

    ... of 10.98% during the forecast period 2024-2030. North American market for Lyophilized Reagent Beads is estimated to increase from $ 111.73 million in 2023 to reach $ 224.94 million by 2030, at a CAGR of ... Read More

  • Booster Compressors

    ... at a CAGR of 5.3% over the analysis period 2023-2030. Air Cooling, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$3.3 Billion by the end of ... Read More

  • Consumer IAM

    ... at a CAGR of 15.0% over the analysis period 2023-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$14.4 Billion by the end of ... Read More

  • Contract Packaging

    ... at a CAGR of 8.7% over the analysis period 2023-2030. Food & Beverage End-Use, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$55.4 Billion by the ... Read More

  • Healthcare Supply Chain Management

    ... reach US$5.4 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2023-2030. Healthcare Supply Chain Management Software, one of the segments analyzed in the report, is expected to record a 10.7% ... Read More

  • Automotive Adaptive Cruise Control

    ... reach US$56.7 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. RADAR Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach ... Read More

  • Carotenoids

    ... of 3.8% over the analysis period 2023-2030. Beta-Carotene, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth ... Read More

Cookie Settings